对于奈玛特韦/利托那韦治疗后COVID-19反弹的患者,应重新开始隔离期(table 1; 图表过大,详见专题)。 详见专题 'COVID-19: Outpatient evaluation and management of acute illness in adults', section on '"Rebound" COVID-19 after nirmatrelvir-ritonavir treatment'. 1. US Food and Drug Administration. ...
在造血干细胞移植或嵌合抗原受体T细胞治疗后,尚无证据明确表明3个月或其他间隔期会使受种者有效产生COVID-19抗体或T细胞介导性免疫,但NCCN依然建议至少等待3个月再接种COVID-19疫苗。 详见专题'Coronavirus disease 2019 (COVID-19): Cancer screening, diagnosis, treatment, and posttreatment surveillance in uninf...
在造血干细胞移植或嵌合抗原受体T细胞治疗后,尚无证据明确表明3个月或其他间隔期会使受种者有效产生COVID-19抗体或T细胞介导性免疫,但NCCN依然建议至少等待3个月再接种COVID-19疫苗。 详见专题'Coronavirus disease 2019 (COVID-19): ...
(See "Treatment of seasonal influenza in adults", section on 'Adjunctive therapies' and "Middle East respiratory syndrome coronavirus: Treatment and prevention", section on 'Treatment'.) 针对COVID-19的抗病毒药物目前正在研究当中。例如,新型核苷...
阿司匹林对2019冠状病毒病(COVID-19)住院患者无效 What's New in UpToDate RECOVERY试验纳入了近15,000例COVID-19住院患者,随机分为单纯标准治疗组和标准治疗联合阿司匹林150mg组,结果发现阿司匹林未降低死亡率或进展为需机械通气的风险[1]。阿司匹林组的血栓形成率小幅降低(4.6% vs 5.3%),而大出血率小幅升高(1.6...
这里给出一个UPTODATE的结论，因为短期使用羟氯喹（和或者不和阿奇霉素一起使用）是相对安全的，所以一些...
2. Centers for Disease Control and Prevention. COVID-19 rebound after Paxlovid treatment. Available at:HAN Archive - 00467(Accessed on May 24, 2022). 2022-06-21·北京 UpToDate临床顾问 作者 详见专题 'COVID-19: Outpatient evaluation and management of acute illness in adults', section on ...
Furtado RHM, Berwanger O, Fonseca HA, et al; COALITION COVID-19 Brazil II Investigators. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised ...
奈玛特韦-利托那韦是口服蛋白酶抑制剂的组合制剂,对于有进展为重症风险的有症状门诊患者,COVID-19特异性治疗优选该方案。 ——UpToDate临床顾问专题 《2019冠状病毒病(COVID-19): 急性成人患者的门诊评估与管理》 UpToDate临床顾问 What's New页面 ...
Clinical Spectrum of SARS-CoV-2 Infection https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum/ Bhimraj A., Morgan R.L., Shumaker A.H., et al. (2020). IDSA Guidelines on the Treatment and Management of Patients with COVID-19. Infectious Diseases Society of America. ...